Thomas F. Ryan Jr. - 01 Mar 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2022, 20:14:08 UTC
Prior SEC filing
04 Nov 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kimberly Brown (Attorney in Fact)

Key filing fact

Thomas F. Ryan Jr. filed Form 4 for REPLIGEN CORP (RGEN) on 02 Mar 2022.

Key facts

  • This page summarizes Thomas F. Ryan Jr.'s Form 4 filing for REPLIGEN CORP (RGEN).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Mar 2022, 20:14.

Change

  • Previous filing in this sequence was filed on 04 Nov 2021.
  • Current net transaction value: -$357,300.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RGEN transaction

Common Stock

Options Exercise

Transaction value
$38,760
Shares
+1,000
Change %
+41%
Price
$38.76
Shares after
3,457
Date
01 Mar 2022
Ownership
Direct
Footnotes
F1
RGEN transaction

Common Stock

Sale

Transaction value
$198,480
Shares
-1,000
Change %
-29%
Price
$198.48
Shares after
2,457
Date
01 Mar 2022
Ownership
Direct
Footnotes
F2
RGEN transaction

Common Stock

Sale

Transaction value
$197,580
Shares
-1,000
Change %
-41%
Price
$197.58
Shares after
1,457
Date
01 Mar 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RGEN transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
+1,000
Change %
Price
$0.000000*
Shares after
0
Date
01 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$38.76
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021.

Footnote F2

$198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

This option is currently exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .